BeStock  
Stocks › Medical Devices › CNMD

ConMed CNMD

US equityMarket cap rank #2930Medical Devices
$46.56 +$0.18 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.56 0.00%
Open$46.11
Prev close$46.38
Day range$45.94 – $48.00
Volume384.3K
Market cap$1.39B
P/E (TTM)19.3
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$335.56M-0.7% YoY
Operating profit$37.14M+212.7% YoY
Net profit$19.80M+592.4% YoY
Diluted EPS$0.66+633.3% YoY
Free cash flow$46.73M-3.7% YoY
Operating cash flow$49.41M

Revenue, last 8 quarters

$345.9MDec '24$321.3MMar '25$342.3MJun '25$337.9MSep '25$373.2MDec '25$317.0MMar '26$343.5MJun '26$335.6MSep '26

Net profit, last 8 quarters

$33.8MDec '24$6.0MMar '25$21.4MJun '25$2.9MSep '25$16.7MDec '25$13.8MMar '26$23.1MJun '26$19.8MSep '26

Diluted EPS by quarter

1.08Dec '240.19Mar '250.69Jun '250.09Sep '250.54Dec '250.45Mar '260.77Jun '260.66Sep '26

Free cash flow by quarter

$39.3MDec '24$37.8MMar '25$23.4MJun '25$48.5MSep '25$41.2MDec '25$10.6MMar '26$34.2MJun '26$46.7MSep '26

Annual revenue

$862.5MFY20$1.0BFY21$1.0BFY22$1.2BFY23$1.3BFY24$1.4BFY25

Profitability & balance sheet

Gross margin57.6%
Operating margin9.9%
Net margin5.4%
Return on equity7.1%
Return on assets3.2%
Return on invested capital5.2%
Current ratio1.49
Liabilities / assets54.0%
Cash & investments$47.97M
Total debt$815.87M
Net cash (debt)-$767.89M
Free cash flow / sales9.7%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • General surgery$186.72M 55.6%
  • Orthopedic surgery$148.83M 44.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $335.56M $343.49M $317.05M $1.37B $373.20M
Total Operating Revenue $335.56M $343.49M $317.05M $1.37B $373.20M
Cost of Revenue $146.41M $146.03M $133.60M $624.25M $154.91M
Gross Profit $189.15M $197.46M $183.45M $750.48M $218.29M
Operating Expense $152.00M $161.05M $158.03M $647.85M $181.66M
Selling and Admin Expenses $136.42M $145.55M $141.70M $591.97M $166.76M
Research & Development $15.59M $15.50M $16.33M $55.88M $14.90M
Operating Profit $37.14M $36.41M $25.42M $102.62M $36.62M
Net Non-Operating Interest Income (Expense) -$11.14M -$7.88M -$7.06M -$31.09M -$7.37M
Non-Operating Interest Expense $11.14M $7.88M $7.06M $31.09M $7.37M
Pretax Profit $26.01M $31.35M $18.36M $71.12M $29.25M
Tax $6.21M $8.28M $4.53M $24.06M $12.51M
Net Profit $19.80M $23.07M $13.83M $47.06M $16.74M
Profit from Continuing Operations $19.80M $23.07M $13.83M $47.06M $16.74M
Net Income to Parent Company $19.80M $23.07M $13.83M $47.06M $16.74M
Net Income to Common Stockholders $19.80M $23.07M $13.83M $47.06M $16.74M
Basic EPS $0.66 $0.77 $0.45 $1.52 $0.54
Diluted EPS $0.66 $0.77 $0.45 $1.51 $0.54
Dividend Per Share $0.00 $0.00 $0.00 $0.60 $0.00
Other Income (Expense) – $2.83M – -$418,000.00 $0.00
Other Non-Operating Income (Expenses) – $2.83M – -$418,000.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.30B $2.30B $2.31B $2.33B $2.33B
Total Current Assets $682.04M $675.67M $670.59M $672.86M $672.86M
Cash and Cash Equivalents & Short-Term Investments $47.97M $37.33M $35.03M $40.82M $40.82M
-Cash and Cash Equivalents $47.97M $37.33M $35.03M $40.82M $40.82M
Receivables $233.91M $239.77M $228.66M $247.83M $247.83M
-Accounts Receivable $233.91M $239.77M $228.66M $247.83M $247.83M
Inventory $362.83M $360.18M $366.11M $355.54M $355.54M
Other Current Assets $37.33M $38.39M $40.79M $28.67M $28.67M
Total Non-Current Assets $1.62B $1.62B $1.64B $1.65B $1.65B
Net PPE $108.77M $110.14M $111.96M $113.33M $113.33M
Goodwill and Other Intangible Assets $1.35B $1.36B $1.38B $1.39B $1.39B
-Goodwill $796.93M $796.90M $806.86M $807.01M $807.01M
-Other Intangible Assets $556.63M $564.42M $573.80M $582.05M $582.05M
Other Non-Current Assets $160.10M $153.18M $151.73M $137.19M $137.19M
Total Liabilities $1.24B $1.26B $1.30B $1.29B $1.29B
Total Current Liabilities $458.96M $455.40M $292.72M $315.04M $315.04M
Payables $98.50M $101.02M $105.42M $93.65M $93.65M
-Accounts Payable $98.50M $101.02M $105.42M $93.65M $93.65M
Short-Term Debt and Capital Lease Obligation $180.11M $177.20M $711,000.00 $712,000.00 $712,000.00
-Current Debt $180.11M $177.20M $711,000.00 $712,000.00 $712,000.00
Other Current Liabilities $103.74M $106.77M $125.70M $138.54M $138.54M
Total Non-Current Liabilities $785.58M $803.52M $1.00B $977.61M $977.61M
Long Term Debt and Capital Lease Obligation $635.76M $657.05M $860.16M $834.23M $834.23M
-Long Term Debt $635.76M $657.05M $860.16M $834.23M $834.23M
Non-Current Deferred Liabilities $88.96M $84.58M $81.38M $79.53M $79.53M
Other Non-Current Liabilities $60.86M $61.88M $63.02M $63.85M $63.85M
Total Equity $1.06B $1.04B $1.02B $1.03B $1.03B
Stockholders' Equity $1.06B $1.04B $1.02B $1.03B $1.03B
Capital Stock $313,000.00 $313,000.00 $313,000.00 $313,000.00 $313,000.00
-Common Stock $313,000.00 $313,000.00 $313,000.00 $313,000.00 $313,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $518.45M $513.46M $508.49M $503.20M $503.20M
Retained Earnings $645.46M $625.67M $602.59M $588.77M $588.77M
Less: Treasury Stock -$60.13M -$54.68M -$49.04M -$12.89M -$12.89M
Gains/Losses Not Affecting Retained Earnings -$44.18M -$43.37M -$44.69M -$46.30M -$46.30M
-Gross PPE – – – $429.96M $429.96M
-Accumulated Depreciation – – – -$316.63M -$316.63M
Non-Current Deferred Assets – – – $13.31M $13.31M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $49.41M $37.10M $13.47M $170.69M $46.34M
Net cash flow from continuing operations $49.41M $37.10M $13.47M $170.69M $46.34M
Net Income from Continuing Operations $19.80M $23.07M $13.83M $47.06M $16.74M
Gain/Loss from Continuing Operations -$312,000.00 -$2.19M -$3.92M $363,000.00 $0.00
Depreciation & Depletion & Amortization $19.18M $19.05M $18.84M $74.28M $18.85M
Deferred Tax $4.60M $2.15M $1.54M $3.52M $812,000.00
Other Non-Cash Items $1.22M $942,000.00 $2.00M $28.60M $20.99M
Change in Working Capital -$980,000.00 -$11.15M -$24.31M -$11.45M -$16.02M
-Change in Receivables $5.72M -$11.35M $18.61M -$2.36M -$22.67M
-Change in Inventory -$1.89M -$1.44M -$12.27M -$6.73M $8.51M
-Change in Payables and Accrued Expense $3.97M $5.20M -$10.67M $5.16M -$7.69M
-Change in Other Current Assets -$13.26M $532,000.00 -$17.22M -$13.16M -$225,000.00
-Change in Other Current Liabilities $4.48M -$4.09M -$2.76M $6.19M $6.61M
Net cash flow from investing -$1.87M $11.57M $4.11M -$20.96M -$7.11M
Net Cash Flow from Continuing Investing Activities -$1.87M $11.57M $4.11M -$20.96M -$7.11M
Net PPE Purchase and Sale -$2.68M -$2.93M -$2.89M -$19.81M -$5.11M
Net Business Purchase and Sale $813,000.00 $14.50M $7.00M – –
Financing Cash Flow -$36.96M -$46.23M -$22.55M -$135.82M -$37.37M
Net Cash Flow from Continuing Financing Activities -$36.96M -$46.23M -$22.55M -$135.82M -$37.37M
Net Issuance Payments Of Debt -$18.63M -$19.18M $25.00M -$74.59M -$20.00M
Net Common Stock Issuance -$6.20M -$6.20M -$37.02M – –
Cash Dividends Paid $0.00 $0.00 $0.00 -$24.75M -$6.19M
Net Other Financing Charges -$12.13M -$20.85M -$10.54M -$36.49M -$11.18M
Ending Cash Balance $47.97M $37.33M $35.03M $40.82M $40.82M
Net Change in Cash $10.58M $2.43M -$4.97M $13.91M $1.85M
Beginning Cash Balance $37.33M $35.03M $40.82M $24.46M $38.93M
Effect of Exchange Rate Changes $61,000.00 -$129,000.00 -$814,000.00 $2.45M $34,000.00
Free Cash Flow $46.73M $34.16M $10.58M $150.88M $41.22M
-Change In Other Working Capital – – – -$558,000.00 –
Net Other Investing Changes – – – -$1.15M -$2.00M

Discussion

No comments yet — be the first to weigh in on CNMD.

Sign in to join the discussion.

Scroll to Top